Vic Neufeld Recent News

Where to find Vic Neufeld Online

Vic Neufeld Crunchbase

Vic Neufeld Twitter

Vic Neufeld ISSUU

Articles with Vic Neufeld

Vic Neufeld News URLS

Follow Vic Neufeld on Linkedin

Vic Neufeld Aphria

Final Regulation in the Cannabis Market Enabling the Sale of Edibles, Extracts, and Topical

A final regulation has been made enabling the sale of cannabis edibles, extracts, and topical. It will take effect later this year and a wider selection will be available for the years to come. This is a big move towards improving the current cannabis market. The regulation will kick-start the cannabis industry. Retailers can now offer various cannabis products to drive people to their business.

For retailers to sell cannabis edibles, extracts, and topical, they need to seek an amendment to their license and they can submit their request starting July 15, 2019, and the process would take a few months. The regulation will take effect on October 17, 2019, and until then businesses can start submitting new product notifications (60-day rule).

What are the product requirement for cannabis?

There should only be 10 milligrams of THC per package of cannabis edibles.

For cannabis topical, every package should have a THC limit of 1,000 milligrams.

Cannabis infused gummies and chocolates are allowed provided they do not appeal to the younger market – shape, taste, and color.

Cannabis edibles should be shelf-stable – will not require freezing or refrigeration.

Cannabis market regulation appeals to retailers

The new regulation of cannabis is appealing to retailers across Canada. This will eventually lead to a more competitive market. Since the legalization of adult-use cannabis in October 2018, the regulated industry has an underwhelming growth secondary to limited product selection and slow rollout of new retailers in some parts of Canada like Ontario and British Columbia. The new product category is foreseen to have a positive impact on cannabis sales. It’s a win-win situation for consumers, entrepreneurs, and shareholders.

What to expect in the cannabis market moving forward?

Cannabis edibles will become legal come mid-December, but the initial supply is small. There will be a limited range of products and it will not include something that might appeal to the younger market. Health Canada has released new regulations which include strict packaging and labeling requirements. Each individual package should have a maximum of 10 mg of THC so as to avoid over-consumption. THC is the main psychoactive component in cannabis. Ingesting cannabis may take up to four hours to take effect and the effect can last much longer when compared to smoking cannabis.

All this to limit the appeal of cannabis product, prevent over-consumption, and reduce the risk of food-related illnesses.cannabis vape products

Bottom line, cannabis edibles should be child-resistant, child-proof packaging, and not appealing to the youth. The priority is to protect the kids, protect the health, and look after the welfare of consumers. Health Canada also gives emphasis on displacing the illicit market that has been operating over the decades. Buying from the black market is not a smart decision as you can’t be assured of the potency and authenticity of the product. Most products in the black market contain ingredients that are not fit for human consumption such as insecticides, pesticides, and fertilizers. With Canada’s final regulations on cannabis edibles, consumers can expect  friskier and safer products.

Reference:  https://mjbizdaily.com/massive-step-for-country-as-canada-unveils-rules-for-new-cannabis-products/

Visit our main website here  https://vicneufeld.com/

Vic Neufeld https://vicneufeld.com/

from

 https://vicneufeld.com/final-regulation-in-the-cannabis-market-enabling-the-sale-of-edibles-extracts-and-topical/

Originally posted on Final Regulation in the Cannabis Market Enabling the Sale of Edibles, Extracts, and Topical

New Medical Marijuana Bill For Veterans Under Consideration

In some states, cannabis is used not only for medical purpose but for recreational purpose too. Canada was one of the first countries to legalize medical and recreational cannabis. In the United States, the battle to legalize weed is still on. Some states such as Florida have already legalized medical cannabis use. A few states already followed the move and more are expected to follow in a few years’ time.

Various studies and research were made and revealed that about 80% of people seek cannabis for pain management. About 35% of patients prescribed with opioid drugs for pain management also use cannabis. More than one-third of medical cannabis users have post-traumatic stress disorder and it is the primary reason for the request. About 15% of veterans treated in Department of Veterans Affairs outpatient post-traumatic stress disorder clinics report recent cannabis use.

What is the VA Medicinal Cannabis Research Act?

Veterans are among the people who deal with a lot of health issues such as chronic pain and post-traumatic stress disorders, to name a few. To address such concerns, the members of Congress are set to meet to discuss bills that could allow veterans to use marijuana for medical purposes. These bills are the following:

VA Medicinal Cannabis Research Act – It directs the Veterans Affair’s secretary to conduct a clinical trial about the effects of cannabis on the management of chronic pain and post-traumatic stress disorder in veterans.

Veterans Equal Access Act – It enables the Veterans Affair’s doctors to come up with a recommendation and opinion on participating in the state marijuana programs.

VA Survey of Cannabis Use Act – It requires the Veterans Affairs to enter an agreement with the research and development center funded by the federal government. Specifically, a nationwide survey should be done to assess the cannabis use by veterans.

A bill requiring VA to conduct training in the use of medical cannabis along with medical schools; specifically, mandating them to incorporate education on medical cannabis into their curriculum.

Although the Veterans Affairs is actively taking steps towards using marijuana as a treatment remedy for health conditions experienced by veterans, still it strongly opposes proposed medical marijuana legislation. Marijuana belongs to the Schedule I drug category and as long as the drug category will not change, the VA leadership will follow the regulations set by the Drug Enforcement Agency and the Department of Justice. The opinion of these agencies is the one that matters the most.

The Demand for Medicinal Cannabis for Veteran Patients

The number of veterans suffering from opioid addiction, prescription pill overdose, and committing suicide continues to increase at an alarming rate. This problem can be addressed only if the federal government will make changes to the federal law enabling medical cannabis to be used as a treatment option for veterans. If the veterans fail to get the care and support they need from the Veterans Affairs, they would surely go around it. Hence, it is important for the Veterans Affairs doctors to provide a holistic care to veterans and it includes treatment plans involving medical cannabis.

Reference:  https://connectingvets.radio.com/articles/congress-committee-considers-medical-marijuana-veterans

Check out more news from Vic Neufeld

 

Vic Neufeld https://vicneufeld.com/

from

 https://vicneufeld.com/medical-marijuana-bill-for-veterans/

Originally posted on New Medical Marijuana Bill For Veterans Under Consideration

Vic Neufeld Presentations and Resources

Vic Neufeld Presentations and Resources

Vic Neufeld brings a many valued years of experience to the medical marijuana industry, with an extensive background in business planning and even farming. He served as CEO of Aphria Inc. is responsible for growing the company to be one of the largest medical marijuana companies in the world.

Vic Neufeld is a leader in the industry of medicinal marijuana with years of experience as a CEO at Aphria.

Vic Neufeld https://vicneufeld.com/

from

 https://vicneufeld.com/vic-neufeld-presentations/

Originally posted on Vic Neufeld Presentations and Resources

Vic Neufeld Presentations and Resources

Vic Neufeld Presentations and Resources

Vic Neufeld brings a many valued years of experience to the medical marijuana industry, with an extensive background in business planning and even farming. He served as CEO of Aphria Inc. is responsible for growing the company to be one of the largest medical marijuana companies in the world.

Vic Neufeld is a leader in the industry of medicinal marijuana with years of experience as a CEO at Aphria.

Originally posted on Vic Neufeld Presentations and Resources via Vic Neufeld Medical Marijuana News

Originally posted on Vic Neufeld Presentations and Resources

medical marijuana, Vic Neufeld, Vic Neufeld Medical Marijuana News

American Cannabis Stocks Score Third Consecutive Monthly Decline

The American Cannabis Operator Index extended its post-March weakness again, declining over 8% to 87.35: The good news is that the stocks managed to recover somewhat from the mid-June lows, ending the month 5% higher than where it closed on June 14th. Still, Q2 was quite challenging, as the index lost 23.8% of its value.  The index,

[Read More ...]

Originally posted on American Cannabis Stocks Score Third Consecutive Monthly Decline via Vic Neufeld Medical Marijuana News

Originally posted on American Cannabis Stocks Score Third Consecutive Monthly Decline

medical marijuana, Vic Neufeld, Vic Neufeld Medical Marijuana News

Better Times Ahead for Canadian Cannabis

This is a copy of the June 30th edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, Monday is Canada Day, and we want to not only wish all of our Canadian readers a happy holiday but also to share our perspective over how the rest of the year may

[Read More ...]

Originally posted on Better Times Ahead for Canadian Cannabis via Vic Neufeld Medical Marijuana News

Originally posted on Better Times Ahead for Canadian Cannabis

medical marijuana, Vic Neufeld, Vic Neufeld Medical Marijuana News

Highly Promotional Cannabis Company TransCanna Holdings Makes Bid for Related Party Ahead of Lock-Up Expiration

TransCanna Holdings (CSE: TCAN) (OTC: TCNAF), a relatively new California-focused cannabis company that began trading in January and promptly launched a very aggressive stock promotion campaign during the rally early in the year as its stock went from C$0.80 to almost C$8.00 after its C$0.50 IPO, announced an acquisition on Saturday, June 29th. The company intends

[Read More ...]

Originally posted on Highly Promotional Cannabis Company TransCanna Holdings Makes Bid for Related Party Ahead of Lock-Up Expiration via Vic Neufeld Medical Marijuana News

Originally posted on Highly Promotional Cannabis Company TransCanna Holdings Makes Bid for Related Party Ahead of Lock-Up Expiration

medical marijuana, Vic Neufeld, Vic Neufeld Medical Marijuana News

Cresco Labs Adds Amazon and Sears Technology Veteran Mo Dastagir as Chief Information Officer

CHICAGO, July 01, 2019–(BUSINESS WIRE)–Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CSE: CL) (OTCQX: CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today announced that Mo Dastagir has joined the Company as its new Chief Information Officer. Mr. Dastagir succeeds Zach Marburger, who is taking on a new

[Read More ...]

Originally posted on Cresco Labs Adds Amazon and Sears Technology Veteran Mo Dastagir as Chief Information Officer via Vic Neufeld Medical Marijuana News

Originally posted on Cresco Labs Adds Amazon and Sears Technology Veteran Mo Dastagir as Chief Information Officer

medical marijuana, Vic Neufeld, Vic Neufeld Medical Marijuana News

Canadian Cannabis LPs Give Up More Ground in June

After a 54.9% gain in Q1, the Canadian Cannabis LP Index  gave up a lot of ground in Q2, including a 8.4% decline in June to 894.07: The index remains substantially below the all-time closing high of 1314.33 on September 25th, just ahead of Canadian legalization. It has increased 41.5% since bottoming on December 21st and is up

[Read More ...]

Originally posted on Canadian Cannabis LPs Give Up More Ground in June via Vic Neufeld Medical Marijuana News

Originally posted on Canadian Cannabis LPs Give Up More Ground in June

medical marijuana, Vic Neufeld, Vic Neufeld Medical Marijuana News

Medicine Man Technologies, Inc., Taps Lee Dayton as Chief Administrative Officer

– Brings 25+ years of investment banking experience, corporate development and strategic partnership expertise to the executive management team – Led customer-focused technology initiatives DENVER, July 1, 2019 /PRNewswire/ — Medicine Man Technologies, Inc. (OTCQX: MDCL) (“Medicine Man Technologies” or “Company”), a rapidly growing, vertically integrated cannabis operator, today announced that business strategist industry veteran, Lee A. Dayton, Jr. will join

[Read More ...]

Originally posted on Medicine Man Technologies, Inc., Taps Lee Dayton as Chief Administrative Officer via Vic Neufeld Medical Marijuana News

Originally posted on Medicine Man Technologies, Inc., Taps Lee Dayton as Chief Administrative Officer

medical marijuana, Vic Neufeld, Vic Neufeld Medical Marijuana News

CBD, the Next Superbug Treatment?

New research is emerging that CBD may be part of the next wave of antibiotics used to treat bacterial infections, including superbugs like MRSA.

[Read More ...]

Originally posted on CBD, the Next Superbug Treatment? via Vic Neufeld Medical Marijuana News

Originally posted on CBD, the Next Superbug Treatment?

medical marijuana, Vic Neufeld, Vic Neufeld Medical Marijuana News

Global Cannabis Stock Index Declines 2.2% in June

After a 57.4% rebound in Q1 followed by a narrow decline in April and a sharp one in May, Cannabis stocks, as measured by the Global Cannabis Stock Index, moved slightly lower in June, declining 2.5%: The index, which had 64 qualifying members during the month following the quarterly rebalancing at the end of March, declined

[Read More ...]

Originally posted on Global Cannabis Stock Index Declines 2.2% in June via Vic Neufeld Medical Marijuana News

Originally posted on Global Cannabis Stock Index Declines 2.2% in June

medical marijuana, Vic Neufeld, Vic Neufeld Medical Marijuana News

Nevada Cannabis Operator Flower One Borrows $20 Million at LIBOR Plus 8% with Warrants

Flower One Announces Debt Financing of up to US$30 Million TORONTO, July 2, 2019 /CNW/ – Flower One Holdings Inc. (the “Company”) (CSE: FONE) (OTCQX: FLOOF), today announced that it has entered into a debt financing agreement (the “Agreement”) with RB Loan Portfolio II, LLC for up to US$30,000,000. With the completion and full planting of our flagship 400,000

[Read More ...]

Originally posted on Nevada Cannabis Operator Flower One Borrows $20 Million at LIBOR Plus 8% with Warrants via Vic Neufeld Medical Marijuana News

Originally posted on Nevada Cannabis Operator Flower One Borrows $20 Million at LIBOR Plus 8% with Warrants

medical marijuana, Vic Neufeld, Vic Neufeld Medical Marijuana News

KushCo Holdings Partners with C.A. Fortune to Expand Retail Opportunities for CBD

GARDEN GROVE, CA / ACCESSWIRE / July 2, 2019 / KushCo Holdings, Inc. (OTCQX: KSHB) (“KushCo” or the “Company”), announced that it has partnered with C.A. Fortune, a leading full-service national consumer products sales and marketing agency focused on lifestyle brand partnerships, to provide viable CBD companies access to large scale, conventional retail channels. The groundbreaking partnership

[Read More ...]

Originally posted on KushCo Holdings Partners with C.A. Fortune to Expand Retail Opportunities for CBD via Vic Neufeld Medical Marijuana News

Originally posted on KushCo Holdings Partners with C.A. Fortune to Expand Retail Opportunities for CBD

medical marijuana, Vic Neufeld, Vic Neufeld Medical Marijuana News

Zenabis Taps Tilray for $30 Million Advance Against Cannabis to be Supplied

Zenabis Arranges $30 Million Non-Dilutive Financing via Supply Agreement with Tilray® VANCOUVER, July 2, 2019 /CNW/ – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) today announced that its wholly-owned subsidiary, Zenabis Ltd., has entered into an agreement with High Park Holdings Ltd. (“High Park”) (the “Supply Agreement”), a wholly-owned subsidiary of Tilray, Inc. (NASDAQ:TLRY)

[Read More ...]

Originally posted on Zenabis Taps Tilray for $30 Million Advance Against Cannabis to be Supplied via Vic Neufeld Medical Marijuana News

Originally posted on Zenabis Taps Tilray for $30 Million Advance Against Cannabis to be Supplied

medical marijuana, Vic Neufeld, Vic Neufeld Medical Marijuana News

California Cannabis Edibles Manufacture Kiva Confections Thrives After Challenges of Regulatory Change

Exclusive Interview with Kiva Confections Founders Scott Palmer and Kristi Knoblich Palmer Since launching in 2010, Kiva Confections has significantly grown its presence, pivoted to manage California’s shift toward more regulation and added to its product portfolio. Founders Kristi Knoblich Palmer and Scott Palmer spoke with New Cannabis Ventures about their company’s approach to customer

[Read More ...]

Originally posted on California Cannabis Edibles Manufacture Kiva Confections Thrives After Challenges of Regulatory Change via Vic Neufeld Medical Marijuana News

Originally posted on California Cannabis Edibles Manufacture Kiva Confections Thrives After Challenges of Regulatory Change

medical marijuana, Vic Neufeld, Vic Neufeld Medical Marijuana News

Kannaway Joins European Industrial Hemp Association

First-ever direct selling CBD hemp oil company Kannaway joins premier hemp industry association within newly opened EU market. 

Medical Marijuana, Inc. subsidiary Kannaway has joined the European Industrial Hemp Association (EIHA) for the first time as a member. This membership will help Kannaway promote the use of renewable hemp and CBD products throughout the European Union.

The EIHA is the only coalition for the industrial hemp sector in Europe. It operates with the goal of uniting the hemp industry in the EU and sharing critical information with its members. The organization also advocates for the cultivation, processing, and use of hemp commercially, lobbies for legislation surrounding hemp and CBD throughout the EU, and organizes events to connect hemp industry leaders in Europe.

As an EIHA member, Kannaway will participate in the organization’s operational and legislative activities as part of Medical Marijuana, Inc.’s mission to bring access to top quality hemp and CBD products to as many people as possible around the world.

“We’re excited to be recognized as a leader in the European hemp industry,” said Kannaway Vice President of International, Alex Grapov. “We look forward to working with the EIHA to help drive global policy changes regarding the legislation of hemp and CBD and help spread education on the potential wellness benefits of CBD.”

The EIHA currently has 52 member businesses and dozens of associate members, including doctors and industry experts. Its members, representing 31 different countries, are players in industrial hemp processing and distribution, car manufacturing, construction, and food and feedstock, as well as the pharmaceutical sector. 

To learn more about the European Industrial Hemp Association, its goals, and to see a list of its members, please visit  http://eiha.org/members/.

According to the Brightfield Group, a predictive market intelligence firm, Europe’s CBD market was estimated at $318 million in 2018 and is expected to grow over 400 percent by 2023. Kannaway was one of the first to introduce hemp products containing high levels of CBD to Europe’s market back in 2017.

Kannaway’s Europe Division has grown exponentially over the last two years. The company has hosted over a dozen events throughout the EU, added more than 50,000 brand ambassadors to its team, and began selling in many new markets and countries. The company now ships to over 30 countries worldwide.

The company officially launched its European operations in 2018 with its Kannaway Grand Opening Event in Prague. More than 2,000 people attended the event where the company revealed several new innovative CBD products and exciting initiatives. 

This led to a significant amount of Kannaway’s 2018 revenue coming from its European operations and the company experienced an increase of nearly 200% in revenue over 2017 revenue.

“Europe has shown us great potential for operational growth and we’re enthusiastic about the future of CBD there,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “Working with the EIHA is a stepping stone to connecting with a larger audience there and helping the CBD industry progress as a whole.”

You can read more about Medical Marijuana, Inc. and our family of companies on our news feed. Interested in trying CBD for yourself? Visit the Medical Marijuana, Inc. store now for our complete line of CBD supplements, vapes, and topicals.

[Read More ...]

Originally posted on Kannaway Joins European Industrial Hemp Association via Vic Neufeld Medical Marijuana News

Originally posted on Kannaway Joins European Industrial Hemp Association

medical marijuana, Vic Neufeld, Vic Neufeld Medical Marijuana News